An inspection of a Tom's of Maine manufacturing facility found that the brand's toothpaste was produced with water containing ...

Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.

Elite Pharmaceuticals ( (ELTP) ) has provided an update.

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...